Literature DB >> 10712673

Redundancy or cell-type-specific regulation? Tumour necrosis factor in alveolar macrophages and mast cells.

R E Déry1, T J Lin, A D Befus, C D Milne, R Moqbel, G Ménard, E Y Bissonnette.   

Abstract

Tumour necrosis factor (TNF) is an important inflammatory cytokine produced by several cell types. To test the hypothesis that there is cell-type-specific regulation and not redundancy of TNF production, we investigated its production by alveolar macrophages (AM) and peritoneal mast cells (PMC). Cell lysates of freshly isolated AM and PMC contained 9 +/- 3 pg and 57 +/- 17 pg of TNF/10(6) cells, respectively. Furthermore, unstimulated PMC expressed 4 x 10(3)-fold more attomols of TNF mRNA/microg total RNA compared with AM. These data may explain in part the greater TNF-dependent cytotoxicity of PMC. Furthermore, fixed PMC showed significantly higher TNF-dependent cytotoxic activity than AM (sevenfold), suggesting that PMC express more membrane TNF than AM. Although AM and PMC contain different amounts of TNF, antigen stimulation caused a similar release of TNF from sensitized rats. Interferon (IFN)-gamma, respectively, stimulated and inhibited AM and PMC TNF-dependent cytotoxicity whereas lipopolysaccharide (LPS) significantly stimulated TNF-dependent cytotoxicity in both cell types. However, TNF released (AM 400-fold and PMC threefold) and TNF mRNA expression, as measured by competitive reverse transcription-polymerase chain reaction (AM 7 x 10(3)-fold and PMC twofold), were considerably greater in LPS-stimulated AM than PMC. Our data indicate that TNF is differentially expressed in these two cell types and that its production is dependent on the nature of the stimulus. These data provide vital basis in experimental approaches aimed at modulating the effect of TNF in airway disease conditions involving both AM and mast cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712673      PMCID: PMC2327162          DOI: 10.1046/j.1365-2567.2000.00982.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors.

Authors:  E Y Bissonnette
Journal:  Am J Respir Cell Mol Biol       Date:  1996-06       Impact factor: 6.914

2.  Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells.

Authors:  E Y Bissonnette; B Chin; A D Befus
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

3.  Optimization of the isolation and effective use of mRNA from rat mast cells.

Authors:  M Gilchrist; A J MacDonald; I Neverova; B Ritchie; A D Befus
Journal:  J Immunol Methods       Date:  1997-02-28       Impact factor: 2.303

4.  Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls.

Authors:  A E Medvedev; T Flo; R R Ingalls; D T Golenbock; G Teti; S N Vogel; T Espevik
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

5.  Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells.

Authors:  Y Tagaya; J D Burton; Y Miyamoto; T A Waldmann
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

6.  Mast cell phagocytosis of FimH-expressing enterobacteria.

Authors:  R Malaviya; E A Ross; J I MacGregor; T Ikeda; J R Little; B A Jakschik; S N Abraham
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

7.  The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms.

Authors:  A Schmidt-Choudhury; G T Furuta; J A Lavigne; S J Galli; B K Wershil
Journal:  Cell Immunol       Date:  1996-07-10       Impact factor: 4.868

8.  Regulation of mRNA levels of TNF-alpha and the alpha chain of the high-affinity receptor for IgE in mast cells by IFN-gamma and alpha/beta.

Authors:  J A Enciso; E Y Bissonnette; A D Befus
Journal:  Int Arch Allergy Immunol       Date:  1996-06       Impact factor: 2.749

Review 9.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

10.  CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol.

Authors:  P Y Perera; S N Vogel; G R Detore; A Haziot; S M Goyert
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.426

View more
  4 in total

1.  A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway.

Authors:  Ryan P Nolan; Andrea G Bree; Anup Zutshi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-09-26       Impact factor: 2.745

2.  Complement activation and cytokine response by BioProtein, a bacterial single cell protein.

Authors:  L I B Sikkeland; E B Thorgersen; T Haug; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 3.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

Review 4.  Future Needs in Mast Cell Biology.

Authors:  Gilda Varricchi; Amato de Paulis; Gianni Marone; Stephen J Galli
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.